A detailed history of Ironwood Investment Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ironwood Investment Management LLC holds 6,239 shares of BMY stock, worth $369,785. This represents 0.16% of its overall portfolio holdings.

Number of Shares
6,239
Previous 6,239 -0.0%
Holding current value
$369,785
Previous $259,000 24.32%
% of portfolio
0.16%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $232,384 - $255,936
-3,200 Reduced 33.9%
6,239 $480,000
Q2 2020

Aug 17, 2020

SELL
$54.82 - $64.09 $43,856 - $51,272
-800 Reduced 7.81%
9,439 $555,000
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $57,378 - $74,845
-1,166 Reduced 10.22%
10,239 $657,000
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $183,911 - $218,053
4,300 Added 60.52%
11,405 $578,000
Q3 2017

Nov 01, 2017

BUY
$55.23 - $63.74 $392,409 - $452,872
7,105
7,105 $453,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ironwood Investment Management LLC Portfolio

Follow Ironwood Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Management LLC with notifications on news.